481 related articles for article (PubMed ID: 16081911)
1. Use of fluorescent probes to determine MICs of amphotericin B and caspofungin against Candida spp. and Aspergillus spp.
Peter J; Armstrong D; Lyman CA; Walsh TJ
J Clin Microbiol; 2005 Aug; 43(8):3788-92. PubMed ID: 16081911
[TBL] [Abstract][Full Text] [Related]
2. Multicenter Study of Method-Dependent Epidemiological Cutoff Values for Detection of Resistance in Candida spp. and Aspergillus spp. to Amphotericin B and Echinocandins for the Etest Agar Diffusion Method.
Espinel-Ingroff A; Arendrup M; Cantón E; Cordoba S; Dannaoui E; García-Rodríguez J; Gonzalez GM; Govender NP; Martin-Mazuelos E; Lackner M; Lass-Flörl C; Linares Sicilia MJ; Rodriguez-Iglesias MA; Pelaez T; Shields RK; Garcia-Effron G; Guinea J; Sanguinetti M; Turnidge J
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799206
[TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibility testing of Aspergillus spp. against voriconazole, itraconazole, posaconazole, amphotericin B and caspofungin.
Shi JY; Xu YC; Shi Y; Lü HX; Liu Y; Zhao WS; Chen DM; Xi LY; Zhou X; Wang H; Guo LN
Chin Med J (Engl); 2010 Oct; 123(19):2706-9. PubMed ID: 21034656
[TBL] [Abstract][Full Text] [Related]
4. Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species.
Odds FC; Motyl M; Andrade R; Bille J; Cantón E; Cuenca-Estrella M; Davidson A; Durussel C; Ellis D; Foraker E; Fothergill AW; Ghannoum MA; Giacobbe RA; Gobernado M; Handke R; Laverdière M; Lee-Yang W; Merz WG; Ostrosky-Zeichner L; Pemán J; Perea S; Perfect JR; Pfaller MA; Proia L; Rex JH; Rinaldi MG; Rodriguez-Tudela JL; Schell WA; Shields C; Sutton DA; Verweij PE; Warnock DW
J Clin Microbiol; 2004 Aug; 42(8):3475-82. PubMed ID: 15297486
[TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
Mallié M; Bastide JM; Blancard A; Bonnin A; Bretagne S; Cambon M; Chandenier J; Chauveau V; Couprie B; Datry A; Feuilhade M; Grillot R; Guiguen C; Lavarde V; Letscher V; Linas MD; Michel A; Morin O; Paugam A; Piens MA; Raberin H; Tissot E; Toubas D; Wade A
Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312
[TBL] [Abstract][Full Text] [Related]
6. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of caspofungin compared to amphotericin B, fluconazole, and itraconazole against Candida strains isolated in a Turkish University Hospital.
Arikan S; Sancak B; Hascelik G
Med Mycol; 2005 Mar; 43(2):171-8. PubMed ID: 15832560
[TBL] [Abstract][Full Text] [Related]
8. Antifungal interactions within the triple combination of amphotericin B, caspofungin and voriconazole against Aspergillus species.
O'Shaughnessy EM; Meletiadis J; Stergiopoulou T; Demchok JP; Walsh TJ
J Antimicrob Chemother; 2006 Dec; 58(6):1168-76. PubMed ID: 17071635
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of caspofungin combined with sulfamethoxazole against clinical isolates of Aspergillus spp.
Yekutiel A; Shalit I; Shadkchan Y; Osherov N
Antimicrob Agents Chemother; 2004 Sep; 48(9):3279-83. PubMed ID: 15328085
[TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibilities of Candida spp. to caspofungin: four years of global surveillance.
Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ
J Clin Microbiol; 2006 Mar; 44(3):760-3. PubMed ID: 16517851
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of voriconazole, itraconazole, caspofungin, anidulafungin (VER002, LY303366) and amphotericin B against aspergillus spp.
Serrano Mdel C; Valverde-Conde A; Chávez M M; Bernal S; Claro RM; Pemán J; Ramirez M; Martín-Mazuelos E
Diagn Microbiol Infect Dis; 2003 Feb; 45(2):131-5. PubMed ID: 12614985
[TBL] [Abstract][Full Text] [Related]
12. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.
Espinel-Ingroff A
Rev Iberoam Micol; 2003 Dec; 20(4):121-36. PubMed ID: 15456349
[TBL] [Abstract][Full Text] [Related]
13. Etest ECVs/ECOFFs for Detection of Resistance in Prevalent and Three Nonprevalent
Espinel-Ingroff A; Sasso M; Turnidge J; Arendrup M; Botterel F; Bourgeois N; Bouteille B; Canton E; Cassaing S; Dannaoui E; Dehais M; Delhaes L; Dupont D; Fekkar A; Fuller J; Garcia-Effron G; Garcia J; Gonzalez GM; Govender NP; Guegan H; Guinea J; Houzé S; Lass-Flörl C; Pelaez T; Forastiero A; Lackner M; Magobo R
Antimicrob Agents Chemother; 2021 Oct; 65(11):e0109321. PubMed ID: 34370582
[TBL] [Abstract][Full Text] [Related]
14. Effect of hypoxic conditions on in vitro susceptibility testing of amphotericin B, itraconazole and micafungin against Aspergillus and Candida.
Warn PA; Sharp A; Guinea J; Denning DW
J Antimicrob Chemother; 2004 May; 53(5):743-9. PubMed ID: 15044422
[TBL] [Abstract][Full Text] [Related]
15. Antifungal activity of micafungin against Candida and Aspergillus spp. isolated from pediatric patients in Japan.
Ikeda F; Saika T; Sato Y; Suzuki M; Hasegawa M; Mikawa T; Kobayashi I; Tsuji A
Med Mycol; 2009 Mar; 47(2):145-8. PubMed ID: 18668422
[TBL] [Abstract][Full Text] [Related]
16. Determination of MICs of aminocandin for Candida spp. and filamentous fungi.
Isham N; Ghannoum MA
J Clin Microbiol; 2006 Dec; 44(12):4342-4. PubMed ID: 17021057
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis.
Lalitha P; Shapiro BL; Srinivasan M; Prajna NV; Acharya NR; Fothergill AW; Ruiz J; Chidambaram JD; Maxey KJ; Hong KC; McLeod SD; Lietman TM
Arch Ophthalmol; 2007 Jun; 125(6):789-93. PubMed ID: 17562990
[TBL] [Abstract][Full Text] [Related]
18. Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates.
Pfaller MA; Messer SA; Rhomberg PR; Jones RN; Castanheira M
J Antimicrob Chemother; 2016 Oct; 71(10):2868-73. PubMed ID: 27287236
[TBL] [Abstract][Full Text] [Related]
19. Killing kinetics of caspofungin, micafungin, and amphotericin B against Candida guilliermondii.
Cantón E; Pemán J; Sastre M; Romero M; Espinel-Ingroff A
Antimicrob Agents Chemother; 2006 Aug; 50(8):2829-32. PubMed ID: 16870779
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the fungicidal activities of caspofungin and amphotericin B against Candida glabrata.
Barchiesi F; Spreghini E; Tomassetti S; Arzeni D; Giannini D; Scalise G
Antimicrob Agents Chemother; 2005 Dec; 49(12):4989-92. PubMed ID: 16304162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
